Nice | Ticagrelor for the treatment of acute coronary syndrome ACS

4th November 2011 by Louise Hudman

Ticagrelor is a PO drug which inhibits platelet aggregation. In combination with aspirin it is more effective than clopidogrel + aspirin at reducing the endpoint of MI or death from vascular events.

It will be started by secondary care and continued by cardiologists, so we shouldn’t really have to initiate it.

It will be started in patients who’ve had a STEMI where primary percutaneous coronary intervention (PCI) is considered and also in patients with a NSTEMI who have certain other risk factors.

Read for free

Sign up to access everything.

Three-month free trial

Login

Already a member? Login to view this content.

Login

"LocumDeck helps me find GP locums quickly, and they are very easy to book on the system. "

Leanne Lincoln, Scheduling Co-ordinator at Beccles Medical Centre

See the full list of features within our NASGP membership plans

Membership